All In MedTech

FDA Clearance Tracker · P990028-S007

FOCALSEAL-L SYNTHETIC ABSORBABLE SEALANT

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Dec 4, 2003 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Dec 4, 2003

Approved

Time to decision

22 days

Received Nov 12, 2003. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track No User Fee

Device class

Class II

The decision

FDA number
P990028-S007
Device name
FOCALSEAL-L SYNTHETIC ABSORBABLE SEALANT
Applicant
Genzyme Corp.
Applicant location
Cambridge, MA
Received
Nov 12, 2003
Decided
Dec 4, 2003
Decision
Approved
Supplement type
Normal 180 Day Track No User Fee
Reason for supplement
Location Change - Manufacturer/Sterilizer/Packager/Supplier
Original approval
P990028

Device type

Device class
Class II
Regulation
21 CFR 878.3300

Every decision under product code FTL

FDA's approval statement

As written in FDA's record.

APPROVAL FOR COMPLAINT RETURN AND INVESTIGATION OPERATIONS TO BE TRANSFERRED FROM THE GENZYME FACILITY IN LEXINGTON, MASSACHUSETTS TO THE GENZYME FACILITY IN FARMINGHAM, MASSACHUSETTS.

Source documents

Other decisions for Genzyme Corp.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

No other decisions since 2015 under this exact applicant name.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.